Table 1 Concentration and CRLBs of NAD+, NADH, total NAD, and RR at P20, P40, P90, and P250, respectively.

From: Developmental changes in cerebral NAD and neuroenergetics of an antioxidant compromised mouse model of schizophrenia

AGE [Days]

GENOTYPE

NAD+ [mM]

CRLB [%]

NADH [mM]

CRLB [%]

RR [-]

TOTAL NAD [mM]

P20

WT

0.38 ± 0.06

10 ± 1

0.28 ± 0.07

11 ± 2

1.43 ± 0.47

0.66 ± 0.10

 

Gclm-KO

0.54 ± 0.08

9 ± 2

0.27 ± 0.09

14 ± 3

2.28 ± 0.99

0.81 ± 0.13

P40

WT

0.43 ± 0.13

9 ± 2

0.23 ± 0.06

12 ± 3

1.94 ± 0.56

0.67 ± 0.18

 

Gclm-KO

0.46 ± 0.11

8 ± 1

0.18 ± 0.03

13 ± 2

2.53 ± 0.70

0.64 ± 0.12

P90

WT

0.39 ± 0.15

10 ± 3

0.20 ± 0.06

14 ± 3

2.15 ± 1.06

0.59 ± 0.16

 

Gclm-KO

0.56 ± 0.12

8 ± 2

0.16 ± 0.07

19 ± 4

3.85 ± 1.53

0.68 ± 0.12

P250

WT

0.42 ± 0.13

9 ± 1

0.15 ± 0.06

19 ± 5

3.31 ± 1.55

0.57 ± 0.15

 

Gclm-KO

0.39 ± 0.08

11 ± 1

0.18 ± 0.04

17 ± 3

2.31 ± 0.80

0.56 ± 0.05